Trial Profile
A Phase 3, Randomized, Double-blind, Active-controlled, Multicenter Study to Evaluate the Efficacy and Safety of a Triple Therapy With Tegoprazan, Amoxicillin, and Clarithromycin in H. Pylori Positive Patients
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 16 Jul 2020
Price :
$35
*
At a glance
- Drugs Amoxicillin (Primary) ; Clarithromycin (Primary) ; Tegoprazan (Primary) ; Lansoprazole
- Indications Helicobacter pylori infections; Peptic ulcer
- Focus Registrational; Therapeutic Use
- Sponsors CJ HealthCare; HK inno.N
- 06 May 2020 Status changed from recruiting to completed.
- 30 Aug 2018 Status changed from not yet recruiting to recruiting.
- 04 May 2018 Planned initiation date changed from 30 Apr 2018 to 25 May 2018.